Literature DB >> 21360191

Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.

M Lin1, Y Chen, J Jin, Y Hu, K K Zhou, M Zhu, Y-Z Le, J Ge, R S Johnson, J-X Ma.   

Abstract

AIMS/HYPOTHESIS: Retinal Müller cells are known to produce inflammatory and angiogenic cytokines, which play important roles in diabetic retinopathy. Hypoxia-inducible factor (HIF)-1 has been shown to play a crucial role in retinal inflammation and neovascularisation. We sought to determine the role of Müller cell-derived HIF-1 in oxygen-induced retinopathy (OIR) and diabetic retinopathy using conditional Hif-1α (also known as Hif1a) knockout (KO) mice.
METHODS: Conditional Hif-1α KO mice were generated by crossing mice expressing cyclisation recombinase (cre, also known as P1_gp003) in Müller cells with floxed Hif-1α mice and used for OIR and streptozotocin-induced diabetes to induce retinal neovascularisation and inflammation, respectively. Abundance of HIF-1α and pro-angiogenic and pro-inflammatory factors was measured by immunoblotting and immunohistochemistry. Retinal neovascularisation was visualised by angiography and quantified by counting pre-retinal nuclei. Retinal inflammation was evaluated by leucostasis and vascular leakage.
RESULTS: While the Hif-1α KO mice showed significantly decreased HIF-1α levels in the retina, they exhibited no apparent histological or visual functional abnormalities under normal conditions. Compared with wild-type counterparts, Hif-1α KO mice with OIR demonstrated attenuated overproduction of vascular endothelial growth factor (VEGF) and intercellular adhesion molecule (ICAM)-1, reduced vascular leakage and alleviated neovascularisation in the retina. Under diabetes conditions, disruption of Hif-1α in Müller cells attenuated the increases of retinal vascular leakage and adherent leucocytes, as well as the overproduction of VEGF and ICAM-1. CONCLUSIONS/
INTERPRETATION: Müller cell-derived HIF-1α is a key mediator of retinal neovascularisation, vascular leakage and inflammation, the major pathological changes in diabetic retinopathy. Müller cell-derived HIF-1α is therefore a promising therapeutic target for diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360191      PMCID: PMC6592825          DOI: 10.1007/s00125-011-2081-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.

Authors:  D Zhang; P L Kaufman; G Gao; R A Saunders; J X Ma
Journal:  Diabetologia       Date:  2001-06       Impact factor: 10.122

2.  Neural stem cell properties of Müller glia in the mammalian retina: regulation by Notch and Wnt signaling.

Authors:  Ani V Das; Kavita B Mallya; Xing Zhao; Faraz Ahmad; Sumitra Bhattacharya; Wallace B Thoreson; Ganapati V Hegde; Iqbal Ahmad
Journal:  Dev Biol       Date:  2006-07-29       Impact factor: 3.582

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Quantification of oxygen-induced retinopathy in the mouse.

Authors:  J Browning; C K Wylie; G Gole
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-05       Impact factor: 4.799

6.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function.

Authors:  Sergiu-Bogdan Catrina; Kensaku Okamoto; Teresa Pereira; Kerstin Brismar; Lorenz Poellinger
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

Authors:  R H Amin; R N Frank; A Kennedy; D Eliott; J E Puklin; G W Abrams
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

8.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 9.  Diabetic retinopathy and systemic vascular complications.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Prog Retin Eye Res       Date:  2007-12-08       Impact factor: 21.198

10.  Conditional gene targeting: dissecting the cellular mechanisms of retinal degenerations.

Authors:  Yun-Zheng Le
Journal:  J Ophthalmol       Date:  2010-12-29       Impact factor: 1.909

View more
  55 in total

1.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

2.  S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.

Authors:  Gumeng Cheng; Kailin Tian; Lu Zhang; Ning Yang; Yiqiao Xing; Tao He
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-11       Impact factor: 3.117

3.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

4.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

Review 5.  Müller cells and diabetic retinopathy.

Authors:  Brandon A Coughlin; Derrick J Feenstra; Susanne Mohr
Journal:  Vision Res       Date:  2017-09-05       Impact factor: 1.886

6.  Acetylcholinesterase inhibition ameliorates retinal neovascularization and glial activation in oxygen-induced retinopathy.

Authors:  Qiu-Ping Liu; Xian Zhang; Ya-Zhou Qin; Jing-Lin Yi; Jing-Ming Li
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

7.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24

8.  Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.

Authors:  Yan-Fang Si; Jun Wang; Juan Guan; Li Zhou; Yu Sheng; Juan Zhao
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.

Authors:  Ahamed Hossain; David Heron; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Shusheng Wang; Partha S Bhattacharjee
Journal:  Exp Eye Res       Date:  2016-06-23       Impact factor: 3.467

Review 10.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.